Exelon-15 TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: rivastigmine
Pack: Exelon-15 13.3 mg/24 hours patch, 30, sachet
Brand name
(ARTG)
: EXELON PATCH 15 rivastigmine 13.3mg/24 hours transdermal drug delivery system sachetDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
EXELON / PROMETAX is indicated for the treatment of patients with mild, moderate and severe dementia of the Alzheimer's type.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Drug delivery system, transdermal
- Transdermal
- Circular 15 cm2 transdermal drug delivery system, backing layer (beige), bi-layer adhesive matrix and an oversized rectangular overlapping release liner with dimples. Patch backing is printed with "CNFU" and "Exelon Patch 15 (rivastigmine)"
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Do not Freeze
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 30 transdermal drug delivery systems pack
- 7 transdermal drug delivery systems pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rivastigmine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
